The Potential of Psychedelic Medicine to Transform Mental Health Treatment
White Paper Apr 26, 2021
The promising medical qualities of psychedelics, such as LSD and psilocybin “magic” mushrooms, have been under-researched for decades owing to prevalent misconceptions about the safety and efficacy of these currently illegal drugs.
In this webinar summary we take stock of the current psychedelic innovation landscape and the vast potential for psychedelic treatments in healthcare. We also take a look at the conditions that Beckley Psytech and other prominent research organizations hope to address with psychedelic therapeutics.
This webinar summary covers:
- The unmet needs where psychedelic medicines may have a real impact
- The focus of current psychedelic research efforts and where the most promising progress is being made
- The outlook for psychedelic medicines and assisted psychotherapy as part of the healthcare system of the future
Related White Papers
Vaccination is largely recognized as the most cost-effective way to fight human infectious diseases. Vaccines play a vital role in immunization strategies that have helped to eradicate dangerous pathogens, increase human life expectancy and reduce disabilities and suffering all around the world.READ MORE
Single-cell sequencing is quickly becoming a standard tool in biological research due to the scale and depth of insight it provides across diverse cell populations. The pharmaceutical industry is exploiting single-cell approaches to identify novel therapeutic targets and accelerate promising assets through development.READ MORE